The Effect of Catheter Protector on Catheter Dwell Time and Complications

Browse trials for

• Phlebitis 45

Keywords

• Peripheral Venous Catheterization
• IV House
• Complication
• Phlebitis

Phlebitis

45 studies on the registry are indexed under Phlebitis; 9 are open to participants now.

This study's enrollment of 69 is below the median of 134 across 38 interventional studies indexed under Phlebitis.

Lead sponsor

Karamanoğlu Mehmetbey University is the lead sponsor of 69 studies on the registry; 19 are open to participants now.

Eligibility criteria

Study arms

• Experimental
  I.V. House UltraDressing

  The nurse who will perform the PVC will clean the area where the PVC will be applied with alcohol and cotton wool, let it dry and apply Teflon Introcan Safety I.V. Catheter No. 22-24 (B. Braun Medical Inc. Bethlehem, PA, USA) to the patients and apply the routine intravenous line fixation method of the clinic with a plaster. The patient with the PVC will then fill out an introductory information form. I.V. House UltraDressing (I.V. House, Inc., St. Louis, MO, USA) will be applied according to the manufacturer's instructions and secured with an anti-slip tape without the need for further taping. Catheter-induced complications such as dislodgement, phlebitis, infiltration, extravasation, catheter occlusion and folding of PVCs will be observed and recorded on the PIVC Monitoring Form, Phlebitis Assessment Scale, and the Infiltration Scale and the effect of I.V. House UltraDressing will be evaluated.

  Device: I.V. House UltraDressing

• No intervention
  Control

  The nurse who will perform the PVC application will clean the area where the PVC will be applied with alcohol and cotton wool and leave it to dry, and the patients in both groups will be applied with a Teflon Introcan Safety I.V. Catheter (B. Braun Medical Inc. Bethlehem, PA, USA) numbered 22-24 and the clinic's routine intravenous line fixation method of fixation with a plaster will be applied. After the PVC is inserted, the introductory information form will be filled out and the duration of the stay of the PVC in the vascular access, dislodgement status and catheter-related complications such as dislodgement, phlebitis, infiltration, extravasation, catheter occlusion and folding of the PVCs will be observed and recorded on the PIVC Monitoring Form, Phlebitis Assessment Scale, and the Infiltration Scale form prepared by the researcher. Patients will remain in the study as long as they are hospitalized in the clinic and their PVCs are inserted.

Interventions

• DeviceI.V. House UltraDressing

  I.V. House UltraDressing (I.V. House, Inc., St. Louis, MO, USA) will be applied according to the manufacturer's instructions and secured with an anti-slip tape without the need for further taping. It is intended to prevent complications such as catheter-related displacement, phlebitis, infiltration, extravasation, catheter occlusion, and folding of PVCs.

Primary outcomes

1. PIVC Monitoring Form

   This form is completed with the dates/times of catheter insertion and removal to determine how many days the catheter remained in the patient. This form also includes sections evaluating the anatomical insertion site, catheter diameter, duration of stay, reasons for catheter replacement, extravasation, obstruction, kinking, and displacement.

   Time frame: up to 1 weeks

Secondary outcomes

1. Phlebitis Assessment Scale

   The scale includes grading steps from 0 to 4, with observation of symptoms that can be seen at each stage of phlebitis. With this scale, phlebitis is evaluated as: * Grade 0: no symptoms, * Grade 1: redness and/or pain at the catheter entry site, * Grade 2: redness, pain and/or edema at the catheter entry site, * Grade 3: redness, pain and/or edema at the catheter entry site, red line, palpation of the vein in the form of a cable, Grade 4: redness, pain and/or edema at the catheter entry site, red line, palpation of the vein in the form of a cable and longer than 2.5 cm, purulent discharge.

   Time frame: up to 1 weeks

2. Infiltration Scale

   Infiltration was assessed using a 0-4 grading system throughout data collection. Grade 0 indicated no signs or symptoms of infiltration, while Grades 1-4 represented progressively increasing severity based on clinical findings, including edema, skin changes, pain, and circulatory impairment

   Time frame: up to 1 weeks

3. PIVC Monitoring Form

   Sections in this form are completed to evaluate the reasons for catheter changes, extravasation, obstruction, kinking, and displacement. This form also includes sections to determine the anatomical insertion site, catheter diameter, and the number of days the catheter remained in place (dates/times).

   Time frame: up to 1 weeks

Individual participant data

Plan to share: Undecided